Azithromycin analogue CSY0073 attenuates lung inflammation induced by LPS challenge-Reference-Cited by-同舟云学术

Azithromycin analogue CSY0073 attenuates lung inflammation induced by LPS challenge

Published:2014-03-18 Issue:7 Volume:171 Page:1783-1794
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Balloy V¹²³⁴,Deveaux A¹²,Lebeaux D⁵,Tabary O¹²,le Rouzic P¹²,Ghigo J M⁵,Busson P F⁶⁷,Boëlle P Y⁶⁷,Guez J Guez⁸,Hahn U⁸,Clement A¹²⁹,Chignard M³⁴,Corvol H¹²⁹,Burnet M⁸,Guillot L¹²

Affiliation:

1. INSERM; UMR_S 938; CDR Saint-Antoine; Paris France

2. Sorbonne Universités; UPMC Univ Paris 06, UMR_S 938, CDR Saint-Antoine; Paris France

3. Inserm U874; Paris France

4. Unité de défense Innée et Inflammation; Institut Pasteur; Paris France

5. Unité de Génétique des Biofilms; Institut Pasteur; Paris France

6. INSERM; UMR_S 707; Paris France

7. Sorbonne Universités; UPMC Univ Paris 06, UMR_S 707; Paris France

8. Synovo; Tübingen Germany

9. Pneumologie pédiatrique; APHP; Hôpital Trousseau; Paris France

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.12574/fullpdf

Reference38 articles.

1. Azithromycin for prevention of exacerbations of COPD;Albert;N Engl J Med,2011

2. Azithromycin and the risk of cardiovascular death;Albert;N Engl J Med,2012

3. Long term azithromycin therapy in cystic fibrosis patients: a study on drug levels and sputum properties;Baumann;Can Respir J,2004

4. Starvation, together with the SOS response, mediates high biofilm-specific tolerance to the fluoroquinolone ofloxacin;Bernier;PLoS Genet,2013

5. Absence of the cystic fibrosis transmembrane regulator (Cftr) from myeloid-derived cells slows resolution of inflammation and infection;Bonfield;J Leukoc Biol,2012

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The tale of antibiotics beyond antimicrobials: Expanding horizons;Cytokine;2023-09

2. Sesamol attenuates bleomycin‐induced pulmonary toxicity and fibrosis in experimental animals;Journal of Biochemical and Molecular Toxicology;2023-07-18

3. Immune cell targeted fumaric esters support a role of GPR109A as a primary target of monomethyl fumarate in vivo;Inflammopharmacology;2023-04-01

4. Prospects for macrolide therapy of asthma and COPD;Advances in Pharmacology;2023

5. The Azithromycin Pro-Drug CSY5669 Boosts Bacterial Killing While Attenuating Lung Inflammation Associated with Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus;Antimicrobial Agents and Chemotherapy;2022-09-20